🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 23 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 15/12/1995 | 31,82 | 31,82 | 30,18 | 30,88 | +1,54% | 5,15% | 32.007 |
| 14/12/1995 | 30,41 | 31,82 | 30,41 | 30,41 | +0,00% | 4,62% | 15.522 |
| 13/12/1995 | 31,82 | 31,82 | 30,41 | 30,41 | -1,52% | 4,41% | 7.214 |
| 12/12/1995 | 32,75 | 32,75 | 30,41 | 30,88 | -4,35% | 7,14% | 26.236 |
| 11/12/1995 | 30,88 | 33,22 | 30,88 | 32,28 | +0,00% | 7,58% | 24.927 |
| 08/12/1995 | 31,35 | 32,28 | 30,41 | 32,28 | +2,98% | 5,97% | 19.663 |
| 07/12/1995 | 31,35 | 31,35 | 30,41 | 31,35 | +1,52% | 2,99% | 47.021 |
| 06/12/1995 | 31,35 | 31,35 | 30,41 | 30,88 | -1,49% | 2,99% | 19.503 |
| 05/12/1995 | 31,82 | 31,82 | 30,41 | 31,35 | -1,47% | 4,41% | 38.098 |
| 04/12/1995 | 30,88 | 31,82 | 29,94 | 31,82 | +0,00% | 6,06% | 84.772 |
| 01/12/1995 | 31,82 | 31,82 | 30,41 | 31,82 | +0,00% | 4,41% | 39.167 |
| 30/11/1995 | 30,41 | 31,82 | 30,41 | 31,82 | +3,82% | 4,62% | 74.620 |
| 29/11/1995 | 30,41 | 30,88 | 29,01 | 30,65 | +0,77% | 6,15% | 37.644 |
| 28/11/1995 | 30,41 | 30,41 | 29,01 | 30,41 | +4,84% | 4,62% | 57.948 |
| 27/11/1995 | 30,41 | 30,41 | 29,01 | 29,01 | -4,62% | 4,62% | 19.931 |
| 24/11/1995 | 29,24 | 30,41 | 29,01 | 30,41 | +0,00% | 4,80% | 3.393 |
| 22/11/1995 | 29,01 | 30,41 | 29,01 | 30,41 | +1,56% | 4,84% | 8.710 |
| 21/11/1995 | 30,88 | 30,88 | 29,01 | 29,94 | -1,54% | 6,06% | 17.767 |
| 20/11/1995 | 29,94 | 30,88 | 29,94 | 30,41 | +0,00% | 3,12% | 15.442 |
| 17/11/1995 | 30,88 | 30,88 | 29,01 | 30,41 | +3,17% | 6,06% | 13.038 |
| 16/11/1995 | 30,88 | 30,88 | 29,01 | 29,48 | -4,55% | 6,06% | 25.514 |
| 15/11/1995 | 30,88 | 30,88 | 29,94 | 30,88 | +0,00% | 3,03% | 31.285 |
| 14/11/1995 | 29,94 | 30,88 | 29,94 | 30,88 | +0,00% | 3,12% | 27.892 |
| 13/11/1995 | 30,88 | 30,88 | 29,48 | 30,88 | +0,00% | 4,55% | 21.266 |
| 10/11/1995 | 30,88 | 30,88 | 29,48 | 30,88 | +1,54% | 4,55% | 11.221 |
| 09/11/1995 | 30,41 | 30,41 | 29,48 | 30,41 | +0,00% | 3,08% | 11.515 |
| 08/11/1995 | 29,94 | 30,41 | 29,01 | 30,41 | +1,56% | 4,69% | 23.591 |
| 07/11/1995 | 29,48 | 29,94 | 28,54 | 29,94 | +4,07% | 4,76% | 13.919 |
| 06/11/1995 | 30,41 | 30,41 | 28,54 | 28,77 | -3,91% | 6,15% | 43.201 |
| 03/11/1995 | 30,41 | 30,41 | 29,48 | 29,94 | +1,59% | 3,08% | 11.194 |